Literature DB >> 1620184

Use of phentolamine for cocaine-induced myocardial ischemia.

J E Hollander, W A Carter, R S Hoffman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1620184     DOI: 10.1056/NEJM199207303270517

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  Street drug abuse leading to critical illness.

Authors:  Babak Mokhlesi; Prasad S Garimella; Aaron Joffe; Valerie Velho
Journal:  Intensive Care Med       Date:  2004-03-04       Impact factor: 17.440

Review 2.  Rethinking cocaine-associated chest pain and acute coronary syndromes.

Authors:  Jonathan B Finkel; Gregary D Marhefka
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

Review 3.  Treatment of patients with cocaine-induced arrhythmias: bringing the bench to the bedside.

Authors:  Robert S Hoffman
Journal:  Br J Clin Pharmacol       Date:  2010-05       Impact factor: 4.335

Review 4.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 5.  Cocaine and the heart.

Authors:  M Egred; G K Davis
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

6.  Cocaine-induced microvascular vasoconstriction but differential systemic haemodynamic responses in Yucatan versus Yorkshire varieties of swine.

Authors:  L Miao; B D Núñez; V Susulic; S Wheeler; J P Carrozza; J N Ross; J P Morgan
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

7.  Phentolamine therapy for cocaine-association acute coronary syndrome (CAACS).

Authors:  Gar Ming Chan; Rahul Sharma; Dennis Price; Robert S Hoffman; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2006-09

Review 8.  Cocaine-associated myocardial infarction.

Authors:  J E Hollander
Journal:  J R Soc Med       Date:  1996-08       Impact factor: 5.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.